Fracture thresholds in osteoporosis: implications for hormone replacement treatment. Issue 9 (September 1992)

• Record Type: Journal Article
• Authors: Ryan, P J; Blake, G M; Fogelman, I
• Is Part Of: Annals of the rheumatic diseases. Volume 51:Issue 9(1992)
• Page Start: 1063
• Page End: 1065
• Publication Date: 1992-09
• Subjects: Rheumatism -- Periodicals; 616.723005
• DOI: 10.1136/ard.51.9.1063
• Languages: English
• ISSNs: 0003-4967

Abstract

Abstract : The bone mineral densities of the lumbar spine and femoral neck were determined by dual energy chi ray absorptiometry in 110 women aged 40-82 years (average 65 years) with spinal osteoporosis who had had at least one atraumatic vertebral compression fracture and in 1026 normal women aged 40-79 years (average 52 years). The women with osteoporosis showed a significant decrease in bone mineral density (BMD) at the lumbar spine and femoral neck compared with age matched normal women (sixth decade of life -26% spine, -23% femoral neck; seventh decade -26% spine, -16% femoral neck). The fracture threshold, defined as the 90th centile of spinal BMD for women with osteoporosis, was 0.81 g/cm2 at the lumbar spine and 0.656 g/cm2 at the femoral neck. Five per cent of normal women aged 40-49 years, 20% aged 50-59 years, and 45% aged 60-69 years had a BMD below this threshold. To maintain the bones of women above the fracture threshold until the age of 70 years about 50% of postmenopausal women need hormone replacement therapy. However, if the BMD is to be kept above the fracture threshold for a women's lifetime, e.g. until the age of 80-90 years, then most women will need treatment, though for various lengths of time depending on their initial BMD. Measurements of BMD in postmenopausal women currently help in identifying the risk of osteoporotic fractures but in the lifetime assessment of risk in a single subject they may have a more important role in deciding the duration of hormone replacement therapy.